ARCHIVES

NCI Planning To Switch Drug Development Emphasis From Compound To Human Cancer Oriented Strategy

This article is from The Cancer Letter archive.

Vol. 10 No. 41 | October 26, 1984

Download PDF Visit The Full Archive

Related Articles

Weicker Ready To Fight for Increased NCI, NIH Funding, Objects to Limits On Grants, Positions

March 14, 1986

ICCCR Issues RFP For Cancer Risk Scale

March 6, 1992

Report Criticizes NIH Grant Review

June 16, 1995

Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival

April 27, 2012

National TV Attack On Cancer Program Gets Response From Schmidt; Some NCAB Members Side With Kornberg

June 28, 1974

In Brief: Plastic Surgeon James French Named to NCAB; Clinton Re-Appoints Nienhuis

April 11, 2000